ACAP1 could serve as a novel prognostic biomarker associated with tumor immunity in clear-cell renal cell carcinoma: A comprehensive analysis by integrating bulk and single-cell sequencing

被引：0
|
作者：
Ding, Guixin [1 ]
Yang, Yingying [1 ]
Chu, Yongli [1 ]
Wu, Jitao [1 ]
机构：
[1] Qingdao Univ, Yantai Yuhuangding Hosp, Dept Urol, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2024年 / 47卷 / 09期
关键词：
ACAP1; Tumor microenvironment; ccRCC; Biomarker;
D O I：
10.1016/j.asjsur.2024.05.024
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：4058 / 4060
页数：3
相关论文
共 50 条
  • [21] Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma
    Jiang, Aimin
    Ye, Juelan
    Zhou, Ye
    Zhu, Baohua
    Lu, Juan
    Ge, Silun
    Qu, Le
    Xiao, Jianru
    Wang, Linhui
    Cai, Chen
    CELLS, 2023, 12 (03)
  • [22] Identification of an immune subtype-related prognostic signature of clear cell renal cell carcinoma based on single-cell sequencing analysis
    Fan, Zongyao
    Xu, Hewei
    Ge, Qingyu
    Li, Weilong
    Zhang, Junjie
    Pu, Yannan
    Chen, Zhengsen
    Zhang, Sicong
    Xue, Jun
    Shen, Baixin
    Ding, Liucheng
    Wei, Zhongqing
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma
    Lin, Yongshuai
    Zhang, Facai
    Jin, Yinling
    Zhong, Quliang
    Tan, Weiwei
    Liu, Jinyang
    Wu, Zhiping
    APPLIED BIONICS AND BIOMECHANICS, 2022, 2022
  • [24] Integrating machine learning and single-cell sequencing to identify shared biomarkers in type 1 diabetes mellitus and clear cell renal cell carcinoma
    Li, Yi
    Zeng, Rui
    Huang, Yuhua
    Zhuo, Yumin
    Huang, Jun
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [25] Construction of EMT related prognostic signature for kidney renal clear cell carcinoma, through integrating bulk and single-cell gene expression profiles
    Huang, Qi
    Li, Feiyu
    Liu, Li
    Xu, Rui
    Yang, Tao
    Ma, Xiaoyun
    Zhang, Hongmei
    Zhou, Yan
    Shao, Yongxiang
    Wang, Qiaofeng
    Xi, Haifeng
    Ding, Yancai
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [26] Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
    Xia, Zhi-Nan
    Wu, Jing-Gen
    Yao, Wen-Hao
    Meng, Yu-Yang
    Jian, Wen-Gang
    Wang, Teng-Da
    Xue, Wei
    Yu, Yi-Peng
    Cai, Li-Cheng
    Wang, Xing-Yuan
    Zhang, Peng
    Li, Zhi-Yuan
    Zhou, Hao
    Jiang, Zhi-Cheng
    Zhou, Jia-Yu
    Zhang, Cheng
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [27] Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
    Zhi-Nan Xia
    Jing-Gen Wu
    Wen-Hao Yao
    Yu-Yang Meng
    Wen-Gang Jian
    Teng-Da Wang
    Wei Xue
    Yi-Peng Yu
    Li-Cheng Cai
    Xing-Yuan Wang
    Peng Zhang
    Zhi-Yuan Li
    Hao Zhou
    Zhi-Cheng Jiang
    Jia-Yu Zhou
    Cheng Zhang
    Scientific Reports, 12
  • [28] SHC1 serves as a prognostic and immunological biomarker in clear cell renal cell carcinoma: a comprehensive bioinformatics and experimental analysis
    Guo, Zhuangyu
    Cai, Congbo
    Zhou, Kena
    Song, Lingmin
    Wang, Xue
    Chen, Dongying
    Weng, Guobin
    Huang, Shuaishuai
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [29] Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing
    Yue Shi
    Qi Zhang
    Hai Bi
    Min Lu
    Yezhen Tan
    Daojia Zou
    Liyuan Ge
    Zhigang Chen
    Cheng Liu
    Weimin Ci
    Lulin Ma
    Genome Biology, 23
  • [30] Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing
    Shi, Yue
    Zhang, Qi
    Bi, Hai
    Lu, Min
    Tan, Yezhen
    Zou, Daojia
    Ge, Liyuan
    Chen, Zhigang
    Liu, Cheng
    Ci, Weimin
    Ma, Lulin
    GENOME BIOLOGY, 2022, 23 (01)
12345